Michelle Fay Cortez
U.S. is focusing on vitamin E as cause of vaping lung...
MINNEAPOLIS, Minn. – United States health officials are looking closely at vitamin E acetate as a potential cause of the severe lung injuries that...
Opioids given to almost 1 in 4 Medicaid patients, study finds
NEW YORK - Nearly one in four people on Medicaid, the U.S. health program for the poor, received powerful and addictive opioid pain medicines in...
Medtronic heart pump recall deemed life-threatening by FDA
MINNEAPOLIS - Flaws with a heart device that Medtronic PLC bought last month as part of a $1 billion deal have been deemed potentially...
Medtronic to buy Mazor shares, promote surgical system
MINNEAPOLIS - Medtronic PLC, the largest maker of equipment to treat spinal conditions, agreed to help promote Mazor Robotics Ltd.’s guidance system used during...
Medtronic meets profit estimates on sales of new products
MINNEAPOLIS - Medtronic PLC, the world’s biggest maker of heart-rhythm devices, met third-quarter profit estimates as its newest products continue to take market share...
Health care costs continue driving deals for med-tech companies
MINNEAPOLIS - Medical-device companies, under pressure from hospitals and health insurers to keep expenses down, are capitalizing on strong cash flows and the stumbling...
Medtronic’s overseas tax move freed up $9.3B
MINNEAPOLIS - Medtronic PLC’s decision to move its tax address out of the U.S. is already starting to pay dividends.
The medical device company used...
Medtronic profit beats estimates on new heart device demand
Medtronic PLC, the world’s biggest maker of heart-rhythm devices, reported first-quarter profit that topped analysts’ estimates on strong demand for its newest products to...
Medtronic joins mitral valve race in $458M device deal
MINNEAPOLIS - Medtronic PLC will spend as much as $458 million to buy Twelve Inc., becoming the latest medical-device giant to buy an experimental...
Gilead’s gaffe leads drugmakers to pledge more openness on price
SAN FRANCISCO - Drugmakers worried about a backlash over soaring drug prices are increasingly talking with insurers ahead of time about paying for new...